Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million

Please enable cookies. Error 1015 Ray ID: a13544c12ed38672 • 2026-06-29 13:27:25 UTC You are being rate limited What happened? The owner of this website (investors.viridiantherapeutics.com) has banned you temporarily from accessing this website. Please see https://developers.cloudflare.com/support/troubleshooting/http-status-codes/cloudflare-1xxx-errors/error-1015/ for more details. Was this page helpful? Yes No Thank you for your feedback! Cloudflare Ray ID: a13544c12ed38672 • Your IP: Click to reveal 81.193.37.7 • Performance & security by Cloudflare